Acceder Registro /

JOSE PADILLA RUIZ

Buscador

Sánchez-Guiu I, Antón AI, Padilla J, Velasco F, Lucia JF, Lozano M, Cid AR, Sevivas T, Lopez-Fernandez MF, Vicente V, González-Manchón C, Rivera J, Lozano ML. Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study. Orphanet J Rare Dis. 2014 Dec 24;9:213. doi: 10.1186/s13023-014-0213-6. PubMed PMID: 25539746; PubMed Central PMCID: PMC4302577.
AÑO: 2014; IF: 3.523
Cerezo-Manchado JJ, Roldan V, Rosafalco M, Anton AI, Arroyo AB, Garcia-Barbera N, Martínez AB, Padilla J, Corral J, Vicente V, Gonzalez-Conejero R. Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment. Pharmacogenomics. 2014 May;15(7):987-96. doi: 10.2217/pgs.13.232. PubMed PMID: 24956252.
AÑO: 2014; IF: 3.218
Muñoz-Ballester J, Chen-Liang TH, Hurtado AM, Heras I, de Arriba F, García-Malo MD, Iniesta P, Lozano ML, Nieto JB, Ortuño FJ, Osma Mdel M, Padilla J, Teruel-Montoya R, Vicente V, Castilla-Llorente C, Jerez A. Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: kinetics, clinical impact and absence of STAT3 mutations. Br J Haematol. 2016 Mar;172(6):937-46. doi: 10.1111/bjh.13917. Epub 2016 Jan 5. PubMed PMID: 26728704.
AÑO: 2016; IF: 5.67
Cerezo-Manchado JJ, Roldán V, Corral J, Rosafalco M, Antón AI, Padilla J, Vicente V, González-Conejero R. Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study. Thromb Haemost. 2016 Jan;115(1):117-25. doi: 10.1160/TH14-09-0814. Epub 2015 Nov 5. PubMed PMID: 26538428.
AÑO: 2016; IF: 5.627
de la Morena-Barrio ME, García A, Martínez-Martínez I, Miñano A, Padilla J, Navarro-Fernández J, Roldán V, Águila S, Iniesta JA, Corral J, Vicente V. A new method to quantify ?-antithrombin glycoform in plasma reveals increased levels during the acute stroke event. Thromb Res. 2015 Sep;136(3):634-41. doi: 10.1016/j.thromres.2015.06.039. PubMed PMID: 26186963.
AÑO: 2015; IF: 3.944

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R